Primary Objective The aim of this research study is to develop a comprehensive inventory of symptoms that occur in children with advanced cancer who are receiving a specialist palliative care service. Secondary Objectives * To assess correlation between parent, child and nurse scores on the Memorial Symptom Assessment Scale (MSAS). * To identify symptom prevalence in children with advanced cancer as identified by the child/young person (CYP), nurse and parent (to be analysed separately for parent, child and nurse). * To identify whether there are any symptoms missing from the age appropriate MSAS as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse). * To identify whether any items on the age appropriate MSAS are not relevant to the population being studied (to be analysed separately for parent, child and nurse). * To identify which symptoms cause the most distress as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse). * To identify degree of severity of each symptom as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse). * To identify which symptoms occur most frequently as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse). * To assess the trends between phase of illness and symptom profile, severity and distress.
Study Type
OBSERVATIONAL
Enrollment
40
Questionnaire based study using a symptom assessment tool
Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom
RECRUITINGPrevalence of all symptoms identified by child using the age appropriate Memorial Symptom Assessment Scale.
Time frame: 18 months
Prevalence of all symptoms identified by the parent using the same assessment tool as the child
Time frame: 18 months
Prevalence of all symptoms identified by the nurse
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.